MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » W.L. Gore picks up bankrupt NMT Medical’s IP at auction

W.L. Gore picks up bankrupt NMT Medical’s IP at auction

By

NMT Medical

W. L. Gore & Associates picked up NMT Medical Inc. (PINK:NMTI) intellectual property and assets at auction as the company faces bankruptcy and attempts to repay creditors.

Gore’s purchase includes data related to NMT’s Closure I trial, a study of its Starflex cardiac implant.

The Starflex implant won FDA pre-market approval in April 2009 and the Boston-based company began analyzing its Closure trial data a year later.

The troubles for NMT began June 17, 2010, when it reported that the flagship device failed to meet the primary endpoint of the trial. The news sent NMT’s stock down 79 percent that day, a far cry from an all-time high of $24.56.

Trying to regroup, NMT said it would "tightly manage expenses, preserve cash, evaluate financing alternatives and adjust our operating plan accordingly," as it waited for the final results of the Closure I trial to be completed in November 2010.

In August 2010, the company’s poor stock performance drew a first de-listing warning from the NASDAQ exchange. Later that month, former CEO Frank Martin and chairman James Mahoney stepped down, with COO Richard Davis taking the helm as chairman, president and CEO.

NASDAQ finally ran out of patience with NMT and moved to de-list the company’s stock in February 2011. At the time, NMTI stock was trading around 38 cents per share.

The company chose not to appeal the NASDAQ ruling, according to a filing with the federal Securities & Exchange Commission.

By April, NMT announced that it didn’t have enough money to pay auditors and wouldn’t file an annual report with the SEC. Later that month, the company began liquidating its assets in an attempt to repay creditors.

NMT entered into an Assignment for the Benefit of Creditors, a legal alternative to formal bankruptcy that transfers all of NMT’s assets to a designated party, which can then liquidate assets and distribute the proceeds to creditors.

The company’s intellectual property went up for auction in May.

Gore’s purchase, the details of which were not disclosed, did not include any of NMT’s liabilities or regulatory obligations.

"We made the decision to acquire these assets in the spirit of collaboration and in the interest of advancing scientific and medical understanding," Gore’s medical division stroke business associate Stuart Broyles said in a press release.

In case you missed it

RSS From Medical Design & Outsourcing

  • Ahead of G7 launch, Dexcom CEO plans for ‘more activity than we’ve ever seen’ in 2022
    With a major product approval and launch in its sights, Dexcom prepares for a big year in 2022. Across 2021, Dexcom (NSDQ:DXCM) took several steps forward. The company touted its next-generation G7 continuous glucose monitor (CGM) and announced a major regulatory nod and partnership for real-time application programming interfaces (APIs), to list a couple. As the new year gets underway, expectations for the… […]
  • Former Zimmer Biomet executive has a new job
    Carrie Nichol, the former chief accounting officer of Zimmer Biomet (NYSE:ZBH), has a new job outside of the medtech industry. Nichol, who also served as vice president, controller and principal accounting officer at Zimmer Biomet, is now a VP and controller at Minnetonka, Minnesota-based Cargill. Her departure was among the many notable medtech executive moves… […]
  • Employees say Intuitive, Boston Scientific, J&J, Medtronic are among the best places to work in 2022
    Intuitive Surgical, Boston Scientific, Johnson & Johnson and Medtronic were recently named by Glassdoor as Best Places to Work in 2022 based on employee reviews. Each year, Glassdoor uses feedback that employees have shared on the website over the past 12 months to compile a list of the best places to work for the upcoming… […]
  • Medtronic’s M&A strategy explained by CFO Karen Parkhill
    When Medtronic CFO and EVP Karen Parkhill looks back at the medical device manufacturer’s performance through the COVID-19 pandemic, she recalls a key decision that rankled investors but paid off in the long run. “When I first joined Medtronic, it was shortly after the Covidien merger and we had taken on a lot of debt… […]
  • Loftware acquires Prisym ID
    Loftware announced that it acquired Prisym ID, a provider of regulated content and label management solutions. Prisym ID focuses on clinical trials, medical device and pharmaceutical labeling, with the acquisition set to expand Loftware’s enterprise labeling solution offerings for the medical device and pharmaceutical industries while enhancing Loftware’s end-to-end, cloud-based labeling platform with advanced clinical… […]
  • BD, Pfizer, Wellcome want to improve hospitals’ antimicrobial practices
    BD (NYSE:BDX) announced yesterday that it will collaborate with Pfizer (NYSE:PFE) and Wellcome to advance antimicrobial stewardship practices. The collaboration builds on ongoing efforts to advance the role of diagnostics in addressing the challenge of antimicrobial resistance (AMR), according to a news release. The companies will survey existing diagnostic practices to highlight benefits and gaps… […]
  • iRhythm CEO considers costs on the path to profitability
    Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind. iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it… […]
  • Integer Holdings makes additions to its executive team
    Integer Holdings today announced that it has appointed three new executives to its leadership team. The appointments come as part of a planned transition due to retirements. Margaret Cathy is being promoted to senior VP of quality and regulatory affairs; Andrew Senn is being promoted to senior VP of strategy and business development and McAlister… […]
  • Healthcare venture funding boomed in 2021; expect a slowdown in 2022
    An all-time-high $86 billion of venture capital investments in the U.S. and Europe last year bested 2020’s record haul by more than 30% and grew more than 150% from 2019, according to a new analysis by Silicon Valley Bank. After record-setting quarters in the first half, however, VC investment slowed due to poor performing biopharma… […]
  • Medical technical writers vs. medical writers: What’s the difference?
    By CfPIE Pharmaceutical organizations often have trouble conveying complex medical concepts to “layman” users like patients and the public. Being able to communicate medical device usage instructions, clinical trial results, patient education materials, and other important materials is essential for end-users to get the most out of your products and services while preventing potential health… […]
  • Traco Power touts new encapsulated AC/DC power supplies
    Traco Power this week announced it launched its new TPP 40E and TPP 65E miniature encapsulated AC/DC power supplies. The new AC/DC power supplies have safety approvals for both medical and industrial applications. Each wattage family has six models, offering single outputs of 5, 12, 15, 24, 36, 48V with up to 94% efficiency, according… […]

Leave a Reply